Symbol: DRREDDY
Month: 2024-12
Start Price: ₹1221.75
End Price: ₹1388.50
12M Return: 13.65%
6M Return: 13.65%
3M Return: 13.65%
Volatility: 0.220
Sharpe Ratio: 7.441
Max Drawdown: -0.018
Peer Correlation (DIVISLAB): -0.2131
Peer Correlation (SUNPHARMA): 0.3743
Peer Correlation (HINDUNILVR): 0.0605
Average Peer Correlation: 0.0739

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Dr. Reddy's Laboratories (DRREDDY) has demonstrated strong performance in the last 12 months, with a return of 13.65%. The stock has shown consistent growth across different time frames, with identical returns of 13.65% in the 6-month and 3-month periods. The volatility of the stock is moderate, with a standard deviation of 0.220. The Sharpe Ratio, a measure of risk-adjusted return, is impressive at 7.441, indicating that the stock has generated excess returns relative to its risk. The maximum drawdown, a measure of the stock's downside risk, is relatively low at -0.018.

In terms of peer correlation, DRREDDY has a negative correlation with DIVISLAB, a moderate positive correlation with SUNPHARMA, and a weak positive correlation with HINDUNILVR. The average peer correlation is 0.0739, suggesting that the stock does not closely follow the movements of its peers.

**Recommendation:**

Based on the strong performance, moderate volatility, and impressive risk-adjusted return, I recommend a **BUY** on Dr. Reddy's Laboratories (DRREDDY). The stock's ability to generate consistent returns across different time frames and its relatively low downside risk make it an attractive investment opportunity. Additionally, the low average peer correlation suggests that the stock may offer diversification benefits, making it a valuable addition to a portfolio. However, it is essential to conduct thorough research and consider other factors, such as the company's fundamentals, industry trends, and market conditions, before making a final investment decision.